The maturation of precision medicine into pragmatic, patient‐centered care: A commentary on the 2026 EHA CLL Guidelines
HemaSphere · 2026-10 · 10 (10)
DOI: 10.1002/hem3.70491 ↗Kurz gefasst
Kommentar in der Zeitschrift HemaSphere, online erschienen am 13.10.2026. Verfasst von Stefano Molica und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology Hull York Medical School Hull United Kingdom. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Haematology Hull York Medical School Hull United Kingdom.
- Department of Haematology St James's University Hospital Leeds United Kingdom.
- Centre for Biomedicine, Hull York Medical School Hull United Kingdom.
ORCID-Profile: Stefano Molica, Talha Munir, David Allsup
Zitieren
APA
Molica, S., Munir, T., & Allsup, D. (2026). The maturation of precision medicine into pragmatic, patient‐centered care: A commentary on the 2026 EHA CLL Guidelines. HemaSphere, 10(10). https://doi.org/10.1002/hem3.70491
Vancouver
Molica S, Munir T, Allsup D. The maturation of precision medicine into pragmatic, patient‐centered care: A commentary on the 2026 EHA CLL Guidelines. HemaSphere. 2026;10(10). doi:10.1002/hem3.70491
BibTeX
@article{Molica2026,
author = {Molica, Stefano and Munir, Talha and Allsup, David},
title = {The maturation of precision medicine into pragmatic, patient‐centered care: A commentary on the 2026 EHA CLL Guidelines},
journal = {HemaSphere},
year = {2026},
volume = {10},
number = {10},
doi = {10.1002/hem3.70491}
}
EUVIMED